Akero Therapeutics (AKRO) had the highest return between August 1, 2022 and December 31, 2022 by a mid-cap US stock, returning 427.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Akero Therapeutics (AKRO) | 8/1/2022 - 12/31/2022 | 427.43% |
Madrigal Pharmaceuticals (MDGL) | 8/1/2022 - 12/31/2022 | 364.77% |
Verona Pharma PLC ADR (VRNA) | 8/1/2022 - 12/31/2022 | 360.85% |
Immunovant (IMVT) | 8/1/2022 - 12/31/2022 | 338.27% |
Viking Therapeutics (VKTX) | 8/1/2022 - 12/31/2022 | 215.44% |
Wave Life Sciences (WVE) | 8/1/2022 - 12/31/2022 | 177.78% |
Rhythm Pharmaceuticals (RYTM) | 8/1/2022 - 12/31/2022 | 133.9% |
Biohaven Pharmaceutical (BHVN) | 8/1/2022 - 12/31/2022 | 131.33% |
Weatherford International (WFRD) | 8/1/2022 - 12/31/2022 | 125.31% |
Melco Resorts & Entertainment (MLCO) | 8/1/2022 - 12/31/2022 | 124.17% |
Manchester United (MANU) | 8/1/2022 - 12/31/2022 | 109.8% |
Nuvalent (NUVL) | 8/1/2022 - 12/31/2022 | 104.39% |
Turkcell Iletisim Hizmetleri AS (TKC) | 8/1/2022 - 12/31/2022 | 102.97% |
Roivant Sciences (ROIV) | 8/1/2022 - 12/31/2022 | 101.77% |
Axsome Therapeutics (AXSM) | 8/1/2022 - 12/31/2022 | 100.6% |
F&G Annuities & Life (FG) | 8/1/2022 - 12/31/2022 | 100.1% |
TG Therapeutics (TGTX) | 8/1/2022 - 12/31/2022 | 99.49% |
Transportadora de Gas del Sur SA ADR (TGS) | 8/1/2022 - 12/31/2022 | 97.32% |
Torm PLC Class A (TRMD) | 8/1/2022 - 12/31/2022 | 90.57% |
Miniso Group Holding (MNSO) | 8/1/2022 - 12/31/2022 | 87.96% |
Catalyst Pharmaceuticals (CPRX) | 8/1/2022 - 12/31/2022 | 82.35% |
ADMA Biologics (ADMA) | 8/1/2022 - 12/31/2022 | 82.16% |
Vista Oil Gas ADR (VIST) | 8/1/2022 - 12/31/2022 | 78.36% |
Tidewater (TDW) | 8/1/2022 - 12/31/2022 | 71.88% |
MoonLake Immunotherapeutics (MLTX) | 8/1/2022 - 12/31/2022 | 69.9% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
